Vitamin C enhances in vitro and in vivo development of porcine somatic cell nuclear transfer embryos

Biochem Biophys Res Commun. 2011 Jul 29;411(2):397-401. doi: 10.1016/j.bbrc.2011.06.160. Epub 2011 Jul 2.

Abstract

The reprogramming of differentiated cells into a totipotent embryonic state through somatic cell nuclear transfer (SCNT) is still an inefficient process. Previous studies revealed that the generation of induced pluripotent stem (iPS) cells from mouse and human fibroblasts could be significantly enhanced with vitamin C treatment. Here, we investigated the effects of vitamin C, to our knowledge for the first time, on the in vitro and in vivo development of porcine SCNT embryos. The rate of blastocyst development in SCNT embryos treated with 50μg/mL vitamin C 15h after activation (36.0%) was significantly higher than that of untreated SCNT embryos (11.5%). The enhanced in vitro development rate of vitamin C-treated embryos was associated with an increased acetylation level of histone H4 lysine 5 and higher Oct4, Sox2 and Klf4 expression levels in blastocysts, as determined by real-time PCR. In addition, treatment with vitamin C resulted in an increased pregnancy rate in pigs. These findings suggest that treatment with vitamin C is beneficial for enhancement of the in vitro and in vivo development of porcine SCNT embryos.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascorbic Acid / pharmacology*
  • Cellular Reprogramming / drug effects*
  • Cellular Senescence / drug effects*
  • Cloning, Organism / methods*
  • Embryo Transfer / methods*
  • Embryonic Development / drug effects
  • Kruppel-Like Factor 4
  • Nuclear Transfer Techniques*
  • Swine*
  • Tumor Suppressor Protein p53 / antagonists & inhibitors

Substances

  • KLF4 protein, human
  • Klf4 protein, mouse
  • Kruppel-Like Factor 4
  • Tumor Suppressor Protein p53
  • Ascorbic Acid